---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Johnson & Johnson

🌎 jnj.com

Johnson & Johnson is a focused healthcare company headquartered in New Brunswick, NJ, specializing in Innovative Medicine, Medical Devices & Diagnostics, and Pharmaceuticals. The company is dedicated to tackling complex health challenges through innovation in science and technology, aiming to improve patient care and health outcomes globally.

---

Johnson & Johnson - Latest News and Updates

• Johnson & Johnson MedTech announced a strategic agreement with Responsive Arthroscopy to expand sports soft tissue solutions, and received IDE approval for the OTTAVA™ Robotic Surgical System to support a clinical trial in the United States.
• On November 15, 2024, Janssen-Cilag International NV, a Johnson & Johnson company, announced that the CHMP recommended marketing authorization for the combination of lazertinib and RYBREVANT®▼ (amivantamab) as a new first-line treatment for advanced non-small-cell lung cancer.
• Johnson & Johnson is advancing robotic-assisted technologies to help clinicians detect lung cancer at an earlier stage.
• Johnson & Johnson MedTech Italy participated in the ELLE Active forum, where their President and CEO Gabriele Fischetto discussed the importance of professional alliances in healthcare with Gaya Spolverato.
• Johnson & Johnson is working to develop a treatment for dermatomyositis, a rare autoimmune disease that causes severe muscle weakness.

• Johnson & Johnson is currently seeking an Associate Director, Health Economics and Market Access - Wound Closure and Healing in the United States.
• Johnson & Johnson is currently seeking a Trade & E-commerce Excellence Lead in Czechia.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.